Sector Chart Processa Pharmaceuticals, Inc.
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
18:41:51 14/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.470 USD | -1.20% |
|
-3.50% | -13.89% |
| 07-30 | Processa Pharmaceuticals, Inc. acquired Vidya Therapeutics, Inc. for approximately $320 million. | CI |
| 07-30 | Processa Pharmaceuticals, Inc. - M&A Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.88M | - | - | - | - | - |
| 71.56B | |||||
| 54.43B | |||||
| 27.59B | - | ||||
| 23.91B | |||||
| 23.14B | - |
Select your edition
All financial news and data tailored to specific country editions
